On September 6, the 9th BioCon Expo 2022 International Biopharmaceutical Conference and Exhibition was held in Hangzhou International Expo Center as scheduled. The BioCon Awards Ceremony and the Appreciation Banquet for the 10th Anniversary of Shangtu also started grandly at 17:30 on the evening of the 6th. Puxin Biotech, as the winner of the "Annual Excellence CDMO Honor Award", accepted the invitation of the conference and attended the award ceremony that night.

The conference set up four major awards: Most Valuable Biotechnology Enterprise, Outstanding Founder of Biotechnology Industry of the Year, Outstanding CDMO of the Year Honor Award and Future Star of Bioindustrial Park of the Year. Based on the results of expert review and public voting, Puxin Biotech finally won the [Annual Excellence CDMO Honor Award] for its outstanding strength.

Puxin Biotech focuses on the unique CQDMO innovative service model in the field of cell medicine. While deeply cultivating the CDMO service of cell therapy, it has built a quality control platform for the needs of each stage of the industrialization of cell medicine according to the pain points and needs of the industry, and officially launched the " Quality" as the core CQDMO service system.

The award of Puxin Biotech fully proves that we have been working hard to become the industry's leading provider of cell drug solutions, and we are going all out to accelerate the introduction of more cell drugs to the market. In the future, Puxin Bio will double its responsibilities and will continue to pursue a higher level of development, continue to innovate technology platforms, and benefit more patients.